Authors

• Keisha L. Gibson (ORCID: https://orcid.org/0000-0003-4702-8150)
• Aolin Wang (ORCID: https://orcid.org/0000-0002-3490-648X)
• Chunyi Xu (ORCID: https://orcid.org/0009-0003-4924-5009)
• Kjell Tullus (ORCID: https://orcid.org/0000-0002-6234-6221)
• Adam K. Jauregui
• Bridget L. Balkaran
• Kamyar Kalantar‐Zadeh (ORCID: https://orcid.org/0000-0002-8666-0725)
• Ali Poyan-Mehr
• Mark Bensink (ORCID: https://orcid.org/0000-0002-5940-7898)
• Nisha C. Hazra (ORCID: https://orcid.org/0000-0002-1424-6525)
• Kelly Helm
• Bruce M. Hendry (ORCID: https://orcid.org/0000-0002-7950-7685)
• Justyna Szklarzewicz
• Jingyi Liu (ORCID: https://orcid.org/0000-0001-8432-507X)
• Daniel Gallego (ORCID: https://orcid.org/0000-0002-7596-3974)
• Philip Smith (ORCID: https://orcid.org/0000-0003-3001-0245)
• Zheng‐Yi Zhou (ORCID: https://orcid.org/0000-0001-9014-8479)
• Dale C. Robinson
• Bonnie Schneider
• Ian Nason
• Ute Floege

Institutions

• Boston University (US)
• University of North Carolina at Chapel Hill (US)
• Oracle (United States) (US)
• University of California, Irvine (US)
• Great Ormond Street Hospital (GB)
• Kidney Research UK (GB)
• University Hospitals of Leicester NHS Trust (GB)
• Arkana Laboratories (US)
• Great Lakes Environmental Center (US)
• Therapeutics Clinical Research (US)
• Kaiser Permanente San Francisco Medical Center (US)
• Federación Española de Enfermedades Raras (ES)
• Nephcure Foundation (US)
• University College London (GB)
• Analysis Group (United States) (US)
• RWTH Aachen University (DE)

Publication Details

Journal

Quality of Life Research

Published

2024-10-26

DOI

https://doi.org/10.1007/s11136-024-03813-x

Citations

3

Primary Topic

Renal Diseases and Glomerulopathies

Type

article

Field-Weighted Citation Impact

1.02